Congenital human parvovirus B19 infection with persistent viremia

Clinical Pediatrics

Volumn 54, Issue 5, 2015, Pages 409-413

  Hudson, Anthony C ^a,b   Montegudo, Anna E ^a,b   Steele, Russell W ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS DNA;

ABDOMINAL DISTENSION; ADULT; ANEMIA; ANTIBODY TITER; APGAR SCORE; BLOOD SAMPLING; BODY WEIGHT; CASE REPORT; CESAREAN SECTION; CONGENITAL HUMAN PARVOVIRUS B 19 INFECTION; CONGENITAL INFECTION; DIGESTIVE TUBE; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; EDEMA; ELECTIVE SURGERY; EMERGENCY WARD; ERYTHEMA; ERYTHEMA INFECTIOSUM; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; FEEDING DIFFICULTY; FEMALE; FETUS DISEASE; FETUS HYDROPS; GESTATIONAL AGE; GLOSSOPTOSIS; HEAD CIRCUMFERENCE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEPATOMEGALY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; INTENSIVE CARE UNIT; INTRAUTERINE BLOOD TRANSFUSION; INTUBATION; MICROGNATHIA; MOTHER; NEWBORN; NEWBORN DISEASE; OBSTETRICIAN; OROGASTRIC TUBE; PALPATION; PEDIATRICIAN; PERICARDIAL EFFUSION; POLYMERASE CHAIN REACTION; POSITIVE END EXPIRATORY PRESSURE; PRENATAL EXPOSURE; RASH; RESPIRATORY FAILURE; RETICULOCYTE COUNT; REVIEW; SCALP EDEMA; SKIN PRURITUS; SYSTOLIC HEART MURMUR; TACHYCARDIA; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TRICUSPID VALVE REGURGITATION; VIREMIA; VIRUS LOAD; COMPLICATION; HUMAN PARVOVIRUS B19; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

ADULT; ERYTHEMA INFECTIOSUM; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; INFANT, NEWBORN; PARVOVIRUS B19, HUMAN; PLATELET TRANSFUSION; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIREMIA;

EID: 84926685110     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/0009922814533412     Document Type: Review

References (27)

1. Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet. 1975 ; 1: 72-73
2. Young N, Mortimer P. Viruses and bone marrow failure. Blood. 1984 ; 63: 729-737
3. Serjeant GR, Serjeant BE, Thomas PW, Anderson MJ, Patou G, Pattison JR. Human parvovirus infection in homozygous sickle cell disease. Lancet. 1993 ; 341: 1237-1240
4. Aguiar FS, Lopes DP, Bazin AR, Setúbal S, Cohen BJ, Nascimento JP. Human parvovirus B19 infection in HIV-positive patients. Rev Soc Bras Med Trop. 2001 ; 34: 239-242
5. Woolf AD, Campion GV, Chishick A, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med. 1989 ; 149: 1153-1156
6. Schwarz TF, Jäger G, Gilch S. Comparison of seven commercial tests for the detection of parvovirus B19-specific IgM. Zentralbl Bakteriol. 1997 ; 285: 525-530
7. Enders M, Weidner A, Rosenthal T, et al. Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops. J Infect Dis. 2008 ; 197: 58-62
8. Rotbart HA. Human parvovirus infections. Annu Rev Med. 1990 ; 41: 25-34
9. Nunque T, Kusuhara K, Hara T. Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis. J Pediatr Infect Dis. 2002 ; 21: 1133-1136
10. Nicolaides KH, Soothill PW, Clewell WH, Rodeck CH, Mibashan RS, Campbell S. Fetal haemoglobin measurement in the assessment of red cell isoimmunisation. Lancet. 1988 ; 1: 1073-1075
11. Yaegashi N. Pathogenesis of nonimmune hydrops fetalis caused by intrauterine B19 infection. Tohoku J Exp Med. 2000 ; 190: 65-82
12. Tolfvenstam T, Papadogiannakis N, Norbeck O, Petersson K, Broliden K. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet. 2001 ; 357: 1494-1497
13. Enders M, Weidner A, Zoellner I, Searle K, Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn. 2004 ; 24: 513-518
14. Sarafidis K, Drossou-Agakidou V, Evdoridou I, et al. Hydrothorax as a sole manifestation of congenital parvovirus B19 infection. Am J Perinatol. 2008 ; 25: 551-554
15. Savarese I, De Carolis MP, Costa S, et al. Atypical manifestations of congenital parvovirus B19 infection. Eur J Pediatr. 2008 ; 167: 1463-1466
16. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol. 1998 ; 105: 174-178
17. Ergaz Z, Ornoy A. Parvovirus B19 in pregnancy. Reprod Toxicol. 2006 ; 21: 421-435
18. De Jong EP, Lindenburg IT, van Klink JM, et al. Intrauterine transfusion for parvovirus B19 infection: long-term neurodevelopmental outcome. Am J Obstet Gynecol. 2012 ; 206: 204.e1-204.e5
19. Dembinski J, Haverkamp F, Maara H, Hansmann M, Eis-Hübinger AM, Bartmann P. Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops. BJOG. 2002 ; 109: 1232-1234
20. Tiessen RG, van Elsacker-Niele AM, Vermeij-Keers C, Oepkes D, van Roosmalen J, Gorsira MC. A fetus with a parvovirus B19 infection and congenital anomalies. Prenat Diagn. 1994 ; 14: 173-176
21. Weiland HT, Vermey-Keers C, Salimans MM, Fleuren GJ, Verwey RA, Anderson MJ. Parvovirus B 19 associated with fetal abnormality. Lancet. 1987 ; 1: 682-683
22. Koch WC, Adler SP, Harger J. Intrauterine parvovirus B19 infection may cause an asymptomatic or recurrent postnatal infection. Pediatr Infect Dis J. 1993 ; 12: 747-750
23. Donders GG, Van Lierde S, Van Elsacker-Niele AM, Moerman P, Goubau P, Vandenberghe K. Survival after intrauterine parvovirus B19 infection with persistence in early infancy: a two-year follow-up. Pediatr Infect Dis J. 1994 ; 13: 234-236
24. Vepreková L, Jelínek J, Zeman J. Congenital aplastic anemia caused by parvovirus B19 infection [in Czech]. Cas Lek Cesk. 2001 ; 140: 178-180
25. Von Kaisenberg CS, Jonat W. Fetal parvovirus B19 infection. Ultrasound Obstet Gynecol. 2001 ; 18: 280-288
26. Hsu ST, Chen YT, Huang YF, et al. Prenatal diagnosis and perinatal management of maternal-fetal congenital parvovirus B19 infection. Taiwan J Obstet Gynecol. 2007 ; 46: 417-422
27. Selbing A, Josefsson A, Dahle LO, Lindgren R. Parvovirus B19 infection during pregnancy treated with high-dose intravenous gammaglobulin. Lancet. 1995 ; 345: 660-661